Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Sales | 455 | 71 | 41 | 85 | 19 |
| Cost of Goods | 1 | 0 | 2 | 3 | 0 |
| Gross Profit | 450 | 70 | 50 | 80 | 10 |
| Operating Expenses | 11,011 | 11,300 | 14,642 | 14,333 | 15,010 |
| Operating Income | -10,556 | -11,229 | -14,601 | -14,248 | -14,991 |
| Other Income | 2,906 | 369 | -59 | 298 | 241 |
| Pre-tax Income | -7,650 | -10,860 | -14,660 | -13,950 | -14,750 |
| Net Income Continuous | -7,657 | -10,864 | -14,647 | -13,955 | -14,759 |
| Net Income | $-7,657 | $-10,864 | $-14,647 | $-13,955 | $-14,759 |
| EPS Basic Total Ops | -6.50 | -9.35 | -12.81 | -12.20 | -12.81 |
| EPS Basic Continuous Ops | -6.60 | -9.41 | -12.77 | -12.18 | -12.90 |
| EPS Diluted Total Ops | -6.50 | -9.35 | -12.81 | -12.20 | -12.81 |
| EPS Diluted Continuous Ops | -6.60 | -9.41 | -12.77 | -12.18 | -12.90 |
| EBITDA(a) | $-10,206 | $-10,899 | $-14,281 | $-13,918 | $-14,651 |